March 20 (Reuters) – Cardiovascular Systems Inc:
* CARDIOVASCULAR SYSTEMS – ENTERED INTO AMENDMENT NO. 2 TO SUPPLY AGREEMENT & AMENDMENT NO. 2 TO PRODUCT SCHEDULE WITH FRESENIUS KABI AB
* CARDIOVASCULAR SYSTEMS INC – SUPPLY AMENDMENT PRIMARILY EXTENDS TERM OF SUPPLY AGREEMENT FOR AN ADDITIONAL FORTY-FOUR MONTHS, TO DECEMBER 31, 2024
* CARDIOVASCULAR SYSTEMS INC – PRODUCT SCHEDULE AMENDMENT PRIMARILY UPDATES PRODUCT PRICING SCHEDULE AND RELATED TERMS
* CARDIOVASCULAR SYSTEMS INC – COMPANY IS EXPERIENCING AND MAY EXPERIENCE OTHER DISRUPTIONS AS A RESULT OF COVID-19 OUTBREAK Source: () Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.
